Pre-formulation, Characterization, Spectroscopic Profiling and HPLC Quantification of bioactive Compound for Advanced Antidiabetic Formulation Development
International Journal of Drug Delivery Technology · 05.06.2026 · 16 (49s)
DOI: 10.25258/ijddt.16.49s.63 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.06.2026. Verfasst von Mohit Nagar und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Charantin is an important antidiabetic phytoconstituent of Momordica charantia, with strong potent hypoglycemic properties, which has poor aqueous solubility, stability, and bioavailability, which requires intensive preformulation evaluation prior to developing a formulation. The present studies are investigating the physicochemical behavior, UV spectral behavior, FTIR functional group profile and HPLC analysis of charantin. At pre-formulation analysis, CRT was found to be pale yellow, slightly hygroscopic powder with a melting point of 268°C and very low water solubility, with moderate lipophilicity (log P = 3.40 ± 0.02). The analysis of the UVVisible spectroscopy showed a typical absorption peak at 288 nm, which could be quantitatively estimated and calibrated. The presence of major functional groups such as hydroxyl, glycosidic, aliphatic C-H, carbonyl and unsaturated C=C bonds in FTIR analysis confirmed the materials has a steroidal saponin structure and its HPLC analysis confirmed good isocratic separation with a retention time of 6.2 minutes as well as strong linearity of its 2-20 µg/ml calibration curve (r² = 0.998). Method accuracy was verified at recovery values (98-102%) with insignificant matrix effects. C.V.% of intra and inter day precision was less than 5% showing good reproducibility. LOD (5.32 µg/ml) and LOQ (17.55 µg/ml) had high sensitivity to trace level quantification. The obtained results present important analytical fingerprints and contribute to the elaboration of the progressive delivery methods aimed at enhancing the stability of charantin and its therapeutic effectiveness.
Zitieren
APA
Nagar, M., Alam, S., & Singh, A. P. (2026). Pre-formulation, Characterization, Spectroscopic Profiling and HPLC Quantification of bioactive Compound for Advanced Antidiabetic Formulation Development. International Journal of Drug Delivery Technology, 16(49s). https://doi.org/10.25258/ijddt.16.49s.63
Vancouver
Nagar M, Alam S, Singh AP. Pre-formulation, Characterization, Spectroscopic Profiling and HPLC Quantification of bioactive Compound for Advanced Antidiabetic Formulation Development. International Journal of Drug Delivery Technology. 2026;16(49s). doi:10.25258/ijddt.16.49s.63
BibTeX
@article{Nagar2026,
author = {Nagar, Mohit and Alam, Sanjar and Singh, Ajay Pal},
title = {Pre-formulation, Characterization, Spectroscopic Profiling and HPLC Quantification of bioactive Compound for Advanced Antidiabetic Formulation Development},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {49s},
doi = {10.25258/ijddt.16.49s.63}
}
EUVIMED